Survival analysis of pancreatic cancer patients suggested that high expression of COL10A1 was associated with a poorer prognosis and that knockdown of COL10A1 inhibited the proliferation, migration, and invasion of cells in functional assays [24]. This evidence concerns the gene COL10A1 and pancreatic neoplasm.